Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

BlackRock Health Sciences Opportunities Portfolio

+ Add to Watchlist

BHSRX:US

52.65 USD 0.32 0.60%

As of 09:29:30 ET on 02/27/2015.

Snapshot for BlackRock Health Sciences Opportunities Portfolio (BHSRX)

Year To Date: +7.51% 3-Month: +6.61% 3-Year: +30.47% 52-Week Range: 37.86 - 52.97
1-Month: +5.11% 1-Year: +25.53% 5-Year: - Beta vs SPX: 0.94

Mutual Fund Chart for BHSRX

No chart data available.
  • BHSRX:US 52.65
  • 1M
  • 1Y
Interactive BHSRX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for BHSRX

BlackRock Health Sciences Opportunities Portfolio is an open-end fund incorporated in the USA. The Fund's objective is long-term growth of capital. The Fund normally invests at least 80% of total assets in securities of companies in health sciences and related industries.

Inception Date: 09-12-2011 Telephone: 1-800-441-7762
Managers: THOMAS P CALLAN / ERIN XIE
Web Site: www.blackrock.com

Fundamentals for BHSRX

NAV (on 2015-02-27) 52.65
Assets (M) (on 2015-02-27) 5,370.77
Fund Leveraged N
Minimum Investment 100.00
Minimum Subsequent Investment 0.00

Dividends for BHSRX

Dividend Type Short Term Cap Gain
Dividend Frequency Irreg
Last Dividend Net (on 2014-12-12) 1.65
Dividend Yield (ttm) 6.39

Fees & Expenses for BHSRX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.70
Redemption Fee 0.00
12b1 Fee 0.50
Expense Ratio 1.49

Top Fund Holdings for BHSRX

Filing Date: 12/31/2014
Name Position Value % of Total
Celgene Corp 1,523,238 170,389,403 3.558%
AbbVie Inc 2,268,900 148,476,816 3.100%
Biogen Idec Inc 433,712 147,223,538 3.074%
Amgen Inc 889,710 141,721,906 2.959%
Alexion Pharmaceuticals Inc 740,017 136,925,346 2.859%
UnitedHealth Group Inc 1,322,982 133,740,250 2.792%
Johnson & Johnson 1,169,900 122,336,443 2.554%
Actavis plc 446,146 114,842,442 2.398%
Abbott Laboratories 2,459,500 110,726,690 2.312%
Novartis AG 1,191,600 110,513,127 2.307%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil